Service Development: Assessing Non-attendance Rates in Outpatient Clinics
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00129649|
Recruitment Status : Completed
First Posted : August 12, 2005
Last Update Posted : October 22, 2015
|Condition or disease||Intervention/treatment||Phase|
|Asthma Sleep Apnea Syndromes Tuberculosis COPD||Behavioral: Telephone reminder call||Not Applicable|
Many studies have shown a high non-attendance rate in hospital outpatient clinics. The investigators have found a non-attendance rate of 25% in their asthma clinics and would like to investigate whether a reminder phone call will improve attendance rates. Patients will be randomised into two groups; one group will receive a reminder phone call one week prior to their hospital consultation and the other group will be managed in the standard manner (i.e. no reminder of any sort). The phone calls will be carried out on a Friday afternoon by a respiratory nurse specialist and a research officer for two asthma clinics based on a Wednesday morning and a Thursday afternoon.
To have an 80% chance of detecting a 10% reduction in non-attendance rates (at 5%) 500 patients are required for this study. The rate of non-attendance will be monitored for all the patients in both groups and some demographic information will be recorded for each patient(age, sex, diagnosis and home postcode).
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||500 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Service Development: Assessing Non-attendance Rates in Outpatient Clinics|
|Study Start Date :||May 2005|
|Study Completion Date :||May 2005|
- Attendance rates at respiratory outpatient clinics
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00129649
|NHLI Imperial College|
|London, United Kingdom, W6 8RF|
|Principal Investigator:||Martyn R Partridge, MD FRCP||Imperial College London|